ChEBI

CHEBI:144657 - N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide(d20:1(4E))(1−)

ChEBI Name N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide(d20:1(4E))(1−) ChEBI ID CHEBI:144657 ChEBI ASCII Name N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(d20:1(4E))(1-) Stars This entity has been manually annotated by a third party. Submitter Lucila Aimo Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C78H132N4O45R Net Charge -1 Average Mass (excl. R groups) 1845.886 Monoisotopic Mass (excl. R groups) 1844.81636 SMILES O([C@@H]1[C@H]([C@@H](O[C@@H]([C@@H]1O)CO)O[C@@H]2[C@H]([C@H](O[C@@H]([C@@H]2O)CO)O[C@@H]3[C@H]([C@@H](O[C@@H]([C@@H]3O)CO)O[C@H]4[C@@H]([C@H]([C@@H](O[C@@H]4CO)O[C@@H]5[C@H]([C@@H](O[C@@H]([C@@H]5O)CO)O[C@H]6[C@@H]([C@H]([C@@H](O[C@@H]6CO)OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCCCC)O)NC(=O)*)O)O)O)NC(=O)C)O)O[C@H]7[C@H]([C@@H]([C@@H]([C@@H](O7)C)O)O)O)NC(=O)C)O)[C@]8(O[C@]([C@@H]([C@H](C8)O)NC(C)=O)([C@@H]([C@@H](CO)O)O)[H])C([O-])=O ChEBI Ontology Outgoing N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide(d20:1(4E))(1−) (CHEBI:144657) has part β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide(d20:1(4E)) (CHEBI:144652) N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide(d20:1(4E))(1−) (CHEBI:144657) is a N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide(1−) (CHEBI:144653) N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide(d20:1(4E))(1−) (CHEBI:144657) is a organic molecular entity (CHEBI:50860) Synonyms Sources a neolactoside IV3-α-[NeuNAc-α-(2→3)-Gal-β-(1→3)-GalNAc],IV2-α-Fuc-nLc4Cer(d20:1(4E)) UniProt α-NeuNAc-(2→3)-β-D-Gal-(1→3)-α-D-GalNAc-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-Cer(d20:1(4E))(1−) SUBMITTER blood antigen group type II sialosylgalactosyl-A(d20:1(4E))(1−) SUBMITTER N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-N-acyl-eicosasphing-4-enine(1−) SUBMITTER N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-N-acyl-icosasphingosine(1−) SUBMITTER Citation Type Source 3654659 PubMed citation SUBMITTER